DILIsym Services a Simulations Plus Company

- DILIsym Services, Inc., based in Durham, North Carolina, is a company specializing in the development and licensing of software solutions for the pharmaceutical industry. With a team of 22 employees, DILIsym Services focuses on providing tools and resources to support the development of safe and effective drug therapies. The company's primary products include DILIsym®, NAFLDsym®, IPFsym™, and RENAsym® software applications designed to address various stages of drug development. DILIsym and RENAsym focus on predicting drug-induced liver and kidney injury, respectively. NAFLDsym and IPFsym are utilized for evaluating the efficacy of therapeutic targets and compounds in nonalcoholic fatty liver disease and idiopathic pulmonary fibrosis. These software solutions are offered to pharmaceutical organizations of varying sizes, regulatory agencies, and academic researchers. DILIsym Services distinguishes itself through its comprehensive approach to drug development support. Beyond software licensing, the company provides consulting services that encompass program design, data input, and interpretation of results. This personalized support aims to guide clients through the complexities of drug development, leveraging the expertise of their scientific team. For inquiries or further information, interested parties can visit DILIsym Services' website at simulations-plus.com/dilisym-services.